Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ903,50,00
KB802,50,69
PKN64,6564,68-0,88
Msft441,56441,63-1,93
Nokia3,55853,56251,12
IBM186,73186,820,45
Mercedes-Benz Group AG63,4563,47-0,14
PFE30,1230,131,53
17.07.2024 16:22:55
Indexy online
AD Index online
select
AD Index online
 

  • 17.07.2024 16:17:39
AECOM Tech (ACM, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
91,44 -0,43 -0,39 79 029
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 17.07.2024
Popis společnosti

Business Summary: AECOM is an infrastructure consulting company, providing professional services throughout the project lifecycle. The Company's business is focused primarily on providing fee-based knowledge-based services. The Company's segments include Americas, International and AECOM Capital (ACAP). The Americas segment provides planning, consulting, architectural and engineering design, construction management and program management services to public and private clients in the United States, Canada, and Latin America. The International segment provides planning, consulting, architectural and engineering design services and program management to public and private clients in Europe, the Middle East, India, Africa, and the Asia-Australia-Pacific regions. The ACAP segment primarily invests in and develops real estate projects. It serves public- and private-sector clients worldwide in end markets, such as transportation, facilities, water, governments, environmental and new energy.
Financial Summary: BRIEF: For the six months ended 31 March 2024, Aecom revenues increased 14% to $7.84B. Net income before extraordinary items increased 1% to $208.1M. Revenues reflect Americas segment increase of 17% to $6.08B, International segment increase of 6% to $1.77B, AECOM Capital (ACAP) segment increase of 75% to $700K, Americas segment increase of 17% to $6.08B, Europe, Middle East, Africa segment increase of 18% to $1.12B.



  • Poslední aktualizace: 17.07.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive OfficerThierry Boiron6303.07.202415.12.2004
Deputy Chief Executive Officer, Deputy General Manager, Chief Pharmacist, Pharmaceutical Development DirectorJean-Christophe Michel Bayssat5901.01.201601.01.2016